Interleukin 6-174 G/C promoter polymorphism and pregnancy complications: Results of a prospective cohort study in 1626 pregnant women

American Journal of Reproductive Immunology

Volumn 59, Issue 4, 2008, Pages 347-351

  Stonek, Felix ^a   Metzenbauer, Martin ^a   Hafner, Erich ^a   Philipp, Karl ^a   Tempfer, Clemens ^b  

^a DANUBE HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GUANINE; INTERLEUKIN 6;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FETUS DEATH; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FETAL DEATH; GENE FREQUENCY; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INTERLEUKIN-6; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RISK FACTORS;

EID: 40949141521     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00577.x     Document Type: Article

References (14)

1. Tempfer CB, Schneeberger C, Huber JC: Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004; 5:57-65.
2. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128:127-137 Review.
3. Takacs P, Green KL, Nikaeo A, Kauma SW: Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol 2003; 188:740-744.
4. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91.
5. Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA: Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 2006; 56:135-144.
6. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA: Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714.
7. Bartha JL, Romero-Carmona R, Comino-Delgado R: Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003; 82:1099-1102.
8. Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN: Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 2003; 189:915-918.
9. Clinical Management Guidelines for Obstetrician-Gynecologists. Diagnosis and Management of Preeclampsia and Eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99:159-167.
10. Hohenauer L: Intrauterine Wachstumskurven für den deutschsprachigen Raum. Zentralblatt Geb Perinatol 1980; 184:167-179.
11. Huber M, Mundlein A, Dornstauder E, Schneeberger C, Tempfer CB, Mueller MW: Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Anal Biochem 2002; 303:25-33.
12. Speer EM, Gentile DA, Zeevi A, Pillage G, Huo D, Skoner DP: Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Hum Immunol 2006; 67:915-923.
13. Mattar R, de Souza E, Daher S: Preterm delivery and cytokine gene polymorphisms. J Reprod Med 2006; 51:317-320.
14. Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M: Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 128:175-179.